JP2003052395A - Transplant adequacy determination method - Google Patents
Transplant adequacy determination methodInfo
- Publication number
- JP2003052395A JP2003052395A JP2001242648A JP2001242648A JP2003052395A JP 2003052395 A JP2003052395 A JP 2003052395A JP 2001242648 A JP2001242648 A JP 2001242648A JP 2001242648 A JP2001242648 A JP 2001242648A JP 2003052395 A JP2003052395 A JP 2003052395A
- Authority
- JP
- Japan
- Prior art keywords
- cultured
- transplantation
- tissue
- adequacy
- cultured tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
(57)【要約】
【課題】 移植適正の判定を容易に行うことができる。
【解決手段】 本発明の移植適正判定方法は、培養後の
培養組織を分散処理を行わずに組織状態のまま測定対象
とし、該測定対象である培養組織中の細胞内酵素を反応
させることにより自らは分光学的に測定可能な物質に変
換される酵素活性測定試薬で処理し、その変換後の前記
物質を分光学的に定量し、その定量結果に基づいて前記
培養組織の移植適正を判定するものである。この移植適
正判定方法では、培養後の培養組織を分散処理を行わず
に組織状態のまま測定対象とするので、測定対象に分散
処理によるダメージが加えられることがない。また、酵
素活性測定試薬を用いて培養組織中の細胞内酵素の活性
を定量するが、この酵素活性は生細胞数と相関があるた
め、結果的に生細胞率を数値として得ることができ、細
胞数を顕微鏡下でカウントするという手間がかからな
い。(57) [Summary] [Problem] It is possible to easily determine whether transplantation is appropriate. SOLUTION: The transplantation suitability judging method of the present invention is a method wherein a cultured tissue after culturing is used as a measurement target in a tissue state without performing dispersion treatment, and an intracellular enzyme in the cultured tissue to be measured is reacted. Treats itself with an enzyme activity measurement reagent that is converted to a spectroscopically measurable substance, spectrophotometrically quantifies the converted substance, and determines the transplantation suitability of the cultured tissue based on the quantified result. Is what you do. In this transplantation suitability determination method, since the cultured tissue after culturing is used as a measurement target in a tissue state without performing dispersion treatment, the measurement target is not damaged by the dispersion treatment. In addition, the activity of the intracellular enzyme in the cultured tissue is quantified using an enzyme activity measurement reagent, but since this enzyme activity is correlated with the number of viable cells, the viable cell rate can be obtained as a numerical value as a result, There is no need to count the number of cells under a microscope.
Description
【0001】[0001]
【発明の属する技術分野】本発明は、培養組織の移植適
正判定方法に関する。TECHNICAL FIELD The present invention relates to a method for determining the adequacy of transplantation of cultured tissue.
【0002】[0002]
【従来の技術】従来、培養組織の状態を観察するため
に、生細胞率(Viability)やコロニー形成能
(Colony Forming Ability)を
測定する方法が知られている。2. Description of the Related Art Conventionally, in order to observe the state of cultured tissue, a method of measuring the viability (Viability) and the colony forming ability (Colony Forming Ability) is known.
【0003】生細胞率の測定方法としては、検査者が顕
微鏡下で培養組織を観察しながら血球計算盤を用いて生
細胞数を測定する方法が知られており、その代表的なも
のとしてトリパンブルーによる色素排除試験が挙げられ
る。トリパンブルーによる色素排除試験では、まず培養
組織を分散処理して細胞懸濁液(分散細胞)を調製し、
次いでこの細胞懸濁液とトリパンブルー液とを混和した
あと血球計算盤上に染み込ませ、検査者が顕微鏡下で青
染した細胞数をカウントする。青染されるのは死細胞で
あることから、生細胞率は、全細胞数と青染した細胞数
の差(生細胞数)を全細胞数で除して百分率で表記され
る。As a method for measuring the viable cell rate, a method is known in which an examiner measures the number of viable cells using a hemocytometer while observing the cultured tissue under a microscope. An example is a dye exclusion test using blue. In the dye exclusion test using trypan blue, the cultured tissue is first dispersed to prepare a cell suspension (dispersed cells),
Then, the cell suspension and trypan blue solution are mixed and then allowed to soak on a hemocytometer, and an examiner counts the number of blue-stained cells under a microscope. Since the cells that are blue-stained are dead cells, the viable cell rate is expressed as a percentage by dividing the difference between the total number of cells and the number of blue-stained cells (the number of viable cells) by the total number of cells.
【0004】一方、コロニー形成能の測定方法では、ま
ず培養組織を分散処理して細胞懸濁液を調製し、次いで
細胞を段階希釈して各希釈液をシャーレに再播種し、次
いでインキュベータに入れて培養し、コロニーが形成さ
れたあと細胞を固定してローダニルブルー染色によりコ
ロニー(細胞)を染色し、検査者が顕微鏡下でコロニー
数をカウントする。On the other hand, in the method of measuring the colony forming ability, first, a cultured tissue is dispersed to prepare a cell suspension, and then the cells are serially diluted and each diluted solution is reseeded in a petri dish, and then placed in an incubator. After culturing, colonies are formed, then the cells are fixed, the colonies (cells) are stained with Rhodanil blue staining, and the examiner counts the number of colonies under a microscope.
【0005】[0005]
【発明が解決しようとする課題】ところで、培養後の培
養組織が移植に適しているか否かを判定するにあたって
は、培養組織中の細胞が生きていることが重要であるこ
とから、生細胞率を測定し、その測定値が予め定めた基
準値をクリアしているか否かによって移植適正を判定す
ることが考えられる。By the way, in determining whether or not the cultured tissue after culturing is suitable for transplantation, it is important that the cells in the cultured tissue are alive. It is conceivable that the transplantability is determined based on whether or not the measured value satisfies a predetermined reference value.
【0006】しかしながら、前出のトリパンブルーによ
る色素排除試験では、細胞数を顕微鏡下でカウントする
必要があり、検査者に手間がかかり操作が煩わしいとい
う問題があった。また、培養後の培養組織から分散細胞
を得るために培養組織に対して長時間のトリプシン処理
を行う必要があることから、実際の培養組織に比べてか
なりのダメージを与えた後で生細胞数を調べることにな
り、移植しようとする培養組織内の生細胞数を反映した
適切な結果であるとは必ずしもいえなかった。However, in the above-mentioned dye exclusion test using trypan blue, it is necessary to count the number of cells under a microscope, which is troublesome for an examiner and is troublesome in operation. In addition, since it is necessary to trypsinize the cultured tissue for a long time in order to obtain dispersed cells from the cultured tissue after culturing, the number of viable cells after being significantly damaged compared to the actual cultured tissue Therefore, it could not be said that the result was appropriate because it reflects the number of viable cells in the cultured tissue to be transplanted.
【0007】また、培養後の培養組織が移植に適してい
るか否かを判定するにあたっては、移植後の生着には生
細胞が増殖能力を維持している必要があることから、生
細胞の増殖能力即ちコロニー形成能を測定し、コロニー
形成能の程度に応じて移植適正を判定することも考えら
れる。Further, in determining whether or not the cultured tissue after culturing is suitable for transplantation, it is necessary to maintain the proliferating ability of viable cells for survival after transplantation. It is also possible to measure the proliferative ability, that is, the colony forming ability, and judge the transplantability according to the degree of the colony forming ability.
【0008】しかしながら、前出のローダニルブルー染
色によるコロニー数測定法では、コロニー数を顕微鏡下
でカウントする必要があり、検査者に手間がかかり操作
が煩わしいという問題があった。However, the above-mentioned method for measuring the number of colonies by staining with Rhodanil blue has a problem that it is necessary to count the number of colonies under a microscope, which is troublesome for an inspector and is troublesome to operate.
【0009】本発明は上記課題に鑑みなされたものであ
り、移植適正の判定を容易に行うことができる培養組織
の移植適正判定方法を提供することを目的とする。The present invention has been made in view of the above problems, and it is an object of the present invention to provide a method for determining the adequacy of transplantation of a cultured tissue, which can easily determine the adequacy of transplantation.
【0010】[0010]
【課題を解決するための手段、発明の実施の形態及び発
明の効果】本発明者らは、細胞数やコロニー数を顕微鏡
下で測定することなく培養組織の移植適正を判定する方
法を種々検討した結果、本発明を完成するに至った。即
ち、本発明の第1の培養組織の移植適正判定方法は、培
養後の培養組織を分散処理を行わずに組織状態のまま測
定対象とし、該測定対象である培養組織中の細胞内酵素
を反応させることにより自らは分光学的に測定可能な物
質に変換される酵素活性測定試薬で処理し、その変換後
の前記物質を分光学的に定量し、その定量結果に基づい
て前記培養組織の移植適正を判定するものである。[Means for Solving the Problems, Embodiments of the Invention, and Effects of the Invention] The present inventors have studied various methods for determining the transplantability of a cultured tissue without measuring the number of cells or the number of colonies under a microscope. As a result, the present invention has been completed. That is, the first method for determining the adequacy of transplantation of a cultured tissue of the present invention is to measure a cultured tissue after culturing as a measurement target in a tissue state without performing a dispersion treatment, and measure intracellular enzymes in the culture target tissue. By reacting it is converted into a spectroscopically measurable substance by treatment with an enzyme activity measuring reagent, the substance after the conversion is quantified spectroscopically, and the cultured tissue of the cultured tissue is analyzed based on the quantification result. The suitability for transplantation is determined.
【0011】この移植適正判定方法では、酵素活性測定
試薬を用いて培養組織中の細胞内酵素の活性を分光学的
に定量して数値化するが、この酵素活性は生細胞数と相
関があるため結果的に生細胞数と同一視でき、その数値
でもって移植適正を判定するので、細胞数を顕微鏡下で
カウントするという手間をかけることなく容易に判定で
きる。また、培養組織にダメージを加えることなくその
まま生細胞数を調べるため、ダメージを与えた後に生細
胞数を調べる場合に比べて、移植しようとする培養組織
内の生細胞数を反映した適切な結果が得られる。したが
って、この移植適正判定方法によれば、移植適正の判定
を容易且つ適切に行うことができる。In this method of determining the transplantability, the activity of the intracellular enzyme in the cultured tissue is quantified spectroscopically by using an enzyme activity measuring reagent, and the enzyme activity is correlated with the number of living cells. Therefore, as a result, the number of viable cells can be identified with the number of living cells, and the transplantability is determined based on the number, so that the number of cells can be easily determined without the trouble of counting under a microscope. In addition, since the number of viable cells is checked as it is without damaging the cultured tissue, an appropriate result that reflects the number of viable cells in the cultured tissue to be transplanted, as compared to the case of examining the number of viable cells after giving damage. Is obtained. Therefore, according to this transplantability determining method, it is possible to easily and appropriately determine the transplantability.
【0012】本発明の第2の培養組織の移植適正判定方
法は、培養後の培養組織を分散処理して得られた分散細
胞を再播種し培養してコロニーを形成させて測定対象と
し、該測定対象であるコロニー中の細胞内酵素を反応さ
せることにより自らは分光学的に測定可能な物質に変換
される酵素活性測定試薬で処理し、その変換後の前記物
質を分光学的に定量し、その定量結果に基づいて前記培
養組織の移植適正を判定するものである。The second method for determining the adequacy of transplantation of a cultured tissue according to the present invention is to re-seed and culture the dispersed cells obtained by subjecting the cultured tissue after the culturing to a dispersion treatment to form a colony, which is the object of measurement. By reacting the intracellular enzyme in the colony to be measured, it is converted into a spectroscopically measurable substance by itself, and then treated with an enzyme activity measuring reagent, and the substance after the conversion is spectroscopically quantified. The suitability for transplantation of the cultured tissue is determined based on the quantitative result.
【0013】この移植適正判定方法では、酵素活性測定
試薬を用いてコロニー中の細胞内酵素の活性を分光学的
に定量して数値化するが、この酵素活性はコロニー数と
相関があるため結果的にコロニー数と同一視でき、その
数値でもって移植適正を判定するので、コロニー数を顕
微鏡下でカウントするという手間をかけることなく容易
に判定できる。したがって、この移植適正判定方法によ
れば、移植適正の判定を容易に行うことができる。[0013] In this method of determining the adequacy of transplantation, the activity of an intracellular enzyme in a colony is spectroscopically quantified and quantified using an enzyme activity measuring reagent, but this enzyme activity has a correlation with the number of colonies. Since it can be identified with the number of colonies, and the transplantability is determined based on the number, the number can be easily determined without counting the number of colonies under a microscope. Therefore, according to this transplantability determining method, it is possible to easily determine the transplantability.
【0014】培養組織の移植適正を判定するにあたって
は、細胞が生きていることが重要であると共に、細胞が
生きていたとしても移植後の生着を考慮すれば増殖能力
つまりコロニー形成能を維持していることも重要である
ことから、本発明の第1及び第2の培養組織の移植適正
判定方法の両方を実施して判定することが好ましい。In determining the transplantability of a cultured tissue, it is important that the cells are alive, and even if the cells are alive, the proliferative ability, that is, the colony forming ability is maintained if the engraftment after transplantation is taken into consideration. Since it is also important to perform the determination, it is preferable to carry out the determination by performing both the first and second methods for determining the adequacy of transplantation of cultured tissues of the present invention.
【0015】培養後の培養組織は、培養細胞シートの一
部を切り取って得られた部分培養細胞シートを用いても
よい。培養細胞シートは、どのように作製してもよい
が、例えば、患者の皮膚あるいは口腔粘膜等の一部を採
取して組織工学の手法を用いてシート状に培養すること
により得てもよい。また、部分培養細胞シートとして
は、例えば、培養細胞シートをパンチングすることによ
り得られるパンチ片などが挙げられる。As the cultured tissue after culturing, a partially cultured cell sheet obtained by cutting a part of the cultured cell sheet may be used. The cultured cell sheet may be prepared by any method, but may be obtained, for example, by collecting a part of a patient's skin or oral mucous membrane and culturing it in a sheet form using a tissue engineering technique. Examples of the partially cultured cell sheet include punch pieces obtained by punching the cultured cell sheet.
【0016】酵素活性測定試薬としては、測定対象であ
る培養組織中の細胞内脱水素酵素を反応させることによ
り自らは還元されて特定波長を吸収する物質に変換され
る酸化還元型試薬や、測定対象である培養組織中の細胞
内加水分解酵素を反応させることにより自らは加水分解
を受けて蛍光を発する物質に変換される分解蛍光型試薬
が好ましい。Examples of the enzyme activity measuring reagent include a redox type reagent which is reduced by the reaction of intracellular dehydrogenase in the culture tissue to be measured and converted into a substance absorbing a specific wavelength, and A degradable fluorescence type reagent which is hydrolyzed by itself to be converted into a substance that emits fluorescence by reacting with an intracellular hydrolase in a target cultured tissue is preferable.
【0017】酸化還元型試薬としては、テトラゾリウム
塩かアラマブルー(AlamerBlue)が好まし
い。テトラゾリウム塩としては、乳酸脱水素酵素(LD
H)などの細胞内脱水素酵素の作用により遊離した水素
を電子キャリアを介して受容し還元されてホルマザンと
なるものが好ましく、例えば、XTT、MTT、WST
−1及びWST−8からなる群より選ばれた1つが好ま
しい。なお、各略称に対する化合物名を表1に示す。The redox type reagent is preferably a tetrazolium salt or AlamarBlue. As a tetrazolium salt, lactate dehydrogenase (LD
H) such as H) or the like that accepts hydrogen released by the action of intracellular dehydrogenase via an electron carrier and is reduced to formazane, and examples thereof include XTT, MTT, and WST.
One selected from the group consisting of -1 and WST-8 is preferred. The compound names for each abbreviation are shown in Table 1.
【0018】[0018]
【表1】 [Table 1]
【0019】ここで、ニコチンアミドアデニンジヌクレ
オチド(NAD)−テトラゾリウム系の連鎖反応を化1
式に示す。この化1式において、電子キャリアはPMS
(5−メチルフェナジウム メチルサルフェート)、メ
ルドラブルー、1−メトキシPMSなどが挙げられる。
この連鎖反応においては、脱水素酵素の作用によって基
質とNAD+とが反応して酸化体とNADHが生成し、
このNADHによって電子キャリアが還元されて電子キ
ャリア還元体とNAD+が生成し、この電子キャリア還
元体によってテトラゾリウム塩が還元されてホルマザン
と電子キャリアが生成する。このため、ホルマザンの生
成量と脱水素酵素の活性との間には相関関係がある。一
方、脱水素酵素の活性と生細胞数との間にも相関関係が
あるため、結局、ホルマザンを定量することにより生細
胞数がわかる。このようなNAD−テトラゾリウム系の
酸化還元型試薬としては、(株)同仁化学研究所製のセ
ル・カウンティング・キット−8(WST−8と1−メ
トキシPMSを含む)やセル・カウンティング・キット
(WST−1と1−メトキシPMSを含む)などが挙げ
られる。Here, the chain reaction of the nicotinamide adenine dinucleotide (NAD) -tetrazolium system is shown below.
Shown in formula In this formula 1, the electron carrier is PMS.
(5-methylphenadium methylsulfate), Meldola blue, 1-methoxy PMS and the like.
In this chain reaction, the substrate and NAD + react with each other by the action of dehydrogenase to produce an oxidant and NADH,
The electron carrier is reduced by this NADH to produce an electron carrier reduced product and NAD + , and the tetrazolium salt is reduced by this electron carrier reduced product to produce formazan and an electron carrier. Therefore, there is a correlation between the amount of formazan produced and the activity of dehydrogenase. On the other hand, since there is a correlation between the activity of dehydrogenase and the number of living cells, the number of living cells can be determined by quantifying formazan. Examples of such NAD-tetrazolium-based redox type reagents include Cell Counting Kit-8 (including WST-8 and 1-methoxy PMS) and Cell Counting Kit (manufactured by Dojindo Laboratories). WST-1 and 1-methoxy PMS are included) and the like.
【0020】[0020]
【化1】 [Chemical 1]
【0021】分解蛍光型試薬としては、細胞内エステラ
ーゼによりエステル基が加水分解されて蛍光を発するフ
ルオレセインとなるエステル基含有フルオレセインが好
ましい。このようなエステル基含有フルオレセインとし
ては、例えば、カルセイン−AM(Calcein A
M)が好ましい。この化合物名も前出の表1に示す。こ
のような分解蛍光型試薬としては、(株)同仁化学研究
所製のセル・カウンティング・キット−F(カルセイン
−AM/DMSO溶液)などが挙げられる。As the degradable fluorescence type reagent, an ester group-containing fluorescein which becomes an fluorescein which is hydrolyzed by intracellular esterase to fluorescein is preferable. Examples of such ester group-containing fluorescein include, for example, calcein-AM (Calcein A).
M) is preferred. This compound name is also shown in Table 1 above. Examples of such a degradative fluorescence type reagent include Cell Counting Kit-F (calcein-AM / DMSO solution) manufactured by Dojindo Laboratories.
【0022】[0022]
【実施例】比較例1.トリパンブルーによる色素排除試
験に基づく移植適正評価
(1)培養上皮細胞シートの作製
インフォームド・コンセントを行った患者から約1cm
2の皮膚組織を採取した。採取した皮膚組織は上皮剥離
用培地で処理を行うことにより、真皮層と上皮層とに分
離し、この上皮層をトリプシン処理することで上皮細胞
懸濁液を作製した。次いで、培養フラスコの底面にフィ
ーダ細胞を敷設した後、上皮細胞懸濁液を播種した。フ
ィーダ細胞としては、マイトマイシンCにより増殖能を
抑制したマウス線維芽細胞を使用した。細胞播種後、5
v/v%FBS(ウシ胎児血清)−DMEM(ダルベッ
コ変法イーグル培地)を培養用培地として注入し、フィ
ーダ細胞の存在下で上皮細胞を培養した。上皮細胞のコ
ロニー形成が確認された後、継続的に培養することによ
り、コンフルエント状態を経て重層化(シート化)し、
培養上皮細胞シートが形成された。また、培養上皮細胞
シートが形成される頃には、フィーダ細胞のほとんどは
培養系から排除されていた。EXAMPLES Comparative Example 1. Evaluation of transplantation suitability based on dye exclusion test with trypan blue (1) Preparation of cultured epithelial cell sheet About 1 cm from a patient who gave informed consent
Two skin tissues were collected. The collected skin tissue was treated with an epithelial detachment medium to separate it into a dermis layer and an epithelial layer, and this epithelial layer was trypsinized to prepare an epithelial cell suspension. Next, feeder cells were laid on the bottom surface of the culture flask, and then an epithelial cell suspension was seeded. Mouse fibroblasts whose growth ability was suppressed by mitomycin C were used as feeder cells. 5 after cell seeding
V / v% FBS (fetal bovine serum) -DMEM (Dulbecco's modified Eagle medium) was injected as a culture medium, and epithelial cells were cultured in the presence of feeder cells. After confirming the colony formation of epithelial cells, by continuously culturing, it becomes a stratified (sheeted) through a confluent state,
A cultured epithelial cell sheet was formed. Further, by the time the cultured epithelial cell sheet was formed, most of the feeder cells were excluded from the culture system.
【0023】(2)生細胞率の測定
酵素活性測定の測定試料としては、上述のように作製し
た培養細胞シートについて、6℃、12℃、25℃、3
0℃の恒温下で3例ずつ保存し、保存後2日目、4日
目、8日目、15日目、30日目のものを各々測定試料
として使用した。なお、15日目と30日目は2例のみ
を測定試料として使用した。測定は以下のような手順で
行った。即ち、培養細胞シートをPBS(リン酸緩衝
液)で洗浄したあと細断し、そこに0.1%トリプシン
を加え、ピペッティングを行ったあと37℃で7分間静
置し、再びピペッティングを行ったあと37℃で7分間
静置し、その後血清培地を加えて反応を止め、再びピペ
ッティングを行うことにより細胞懸濁液とした。この細
胞懸濁液に、予め調製しておいたトリパンブルー液を加
えて混和し、この混和液を直ちに血球計算盤にしみ込ま
せ、顕微鏡下で青染した細胞数をカウントした。生細胞
率は数1式により算出した。また、保存日数に対する生
細胞率の変化を表すグラフを図1に示す。なお、図1に
おける生細胞率は3例の平均値とした。但し、15日目
と30日目の生細胞率は2例の平均値とした。(2) Measurement of viable cell rate As a measurement sample for enzyme activity measurement, the cultured cell sheet prepared as described above was 6 ° C, 12 ° C, 25 ° C, 3 ° C.
Three samples were stored at a constant temperature of 0 ° C., and the second, fourth, eighth, fifteenth, and thirtieth days after storage were used as measurement samples. On the 15th and 30th days, only 2 cases were used as measurement samples. The measurement was performed by the following procedure. That is, the cultured cell sheet was washed with PBS (phosphate buffer solution), then shredded, 0.1% trypsin was added thereto, pipetting was performed, and the mixture was allowed to stand at 37 ° C for 7 minutes, and then pipetting again. After that, the mixture was allowed to stand at 37 ° C. for 7 minutes, after which a serum medium was added to stop the reaction, and pipetting was performed again to give a cell suspension. A trypan blue solution prepared in advance was added to and mixed with the cell suspension, and the mixed solution was immediately soaked in a hemocytometer, and the number of blue-stained cells was counted under a microscope. The viable cell rate was calculated by the equation (1). In addition, a graph showing the change in the viable cell rate with respect to the number of storage days is shown in FIG. The viable cell rate in FIG. 1 was the average value of 3 cases. However, the viable cell rate on the 15th and 30th days was the average value of the two cases.
【0024】[0024]
【数1】 [Equation 1]
【0025】(3)移植適正の判定
トリパンブルーによる色素排除試験で得られた生細胞率
に基づいて移植適正判定を行ったときの適合例数を表2
に示した。ここでは移植適正基準値(図1における「適
合値」)を生細胞率25%とし、この基準値を超えたも
のを適合例とした。表2では、測定例数を分母とし、適
合例数を分子とした。(3) Judgment of transplantation suitability The number of cases suitable for transplantation judgment based on the viable cell rate obtained in the dye exclusion test with trypan blue is shown in Table 2.
It was shown to. Here, the transplantation appropriate standard value (“the compatible value” in FIG. 1) was set to 25% of the viable cell rate, and those exceeding this standard value were made the compatible examples. In Table 2, the number of measurement examples was used as the denominator, and the number of compatible cases was used as the numerator.
【0026】[0026]
【表2】 [Table 2]
【0027】実施例1.酵素活性測定に基づく移植適正
評価
(1)培養上皮細胞シートの作製
比較例1の1.と同様にして培養上皮細胞シートを作製
した。Example 1. Evaluation of transplantation suitability based on enzyme activity measurement (1) Preparation of cultured epithelial cell sheet 1. A cultured epithelial cell sheet was prepared in the same manner as in.
【0028】(2)酵素活性測定
酵素活性測定の測定試料としては、上述のように作製し
た培養細胞シートについて、6℃、12℃、25℃、3
0℃の恒温下で保存し、保存後2日目、4日目、8日
目、15日目、30日目のものを各々測定試料として使
用した。測定は以下のような手順で行った。即ち、試料
となる培養細胞シートをφ8mmの大きさで12箇所穿
孔(パンチ)し、48ウェルプレートに各ウェルに4パ
ンチ片ずつ収納した。この際、各ウェルには予め表皮培
養用培地を0.5mlずつ注入しておいた。このように
同一条件の測定試料を3例(3ウェル)設定した。この
48ウェルプレートをCO2インキュベータにおいて3
7℃、10%CO2の条件で2時間培養し、培養後、各
ウェルから培地を0.3ml吸引し、培地残量を0.2
mlとした。次いで、WST−1と1−メトキシPMS
を含む前出のセル・カウンティング・キットの溶液を2
0μl添加して振盪し、CO2インキュベータにおいて
37℃、10%CO2の条件で2時間培養した。この培
養中において、1時間経過した時に再び振盪した。そし
て、2時間培養した後、この48ウェルプレートを冷却
し、その後マイクロピペットで各ウェルの上清110μ
lをサンプリングして、96ウェルプレートに注入し
た。次いで、プレートリーダを使用して96ウェルプレ
ートの各ウェルでのWST−1ホルマザンの吸光度(測
定波長450nm、参照波長650nm)を測定し、培
地単独のブランク値を差し引いた吸光度(△OD
450-650nm/hr、反応1時間当たりの吸光度であり、
OD/hrとも記す)を求めた。その結果を図2に示
す。なお、測定結果は3ウェルの吸光度の平均値とし
た。但し、保存温度30℃を除く15日目と30日目の
測定結果は2ウェルの吸光度の平均値とし、保存温度3
0℃は15日目までで測定を中止し、その15日目の測
定結果は1ウェルの吸光度とした。(2) Enzyme activity measurement As a measurement sample for enzyme activity measurement, the cultured cell sheet prepared as described above was 6 ° C, 12 ° C, 25 ° C, 3 ° C.
The samples were stored at a constant temperature of 0 ° C., and the samples on the 2nd, 4th, 8th, 15th, and 30th days after storage were used as measurement samples. The measurement was performed by the following procedure. That is, a cultured cell sheet to be used as a sample was punched at 12 locations with a size of 8 mm, and 4 punch pieces were stored in each well in a 48-well plate. At this time, 0.5 ml of the epidermal culture medium was injected into each well in advance. In this way, three measurement samples (three wells) under the same conditions were set. This 48-well plate was placed in a CO 2 incubator for 3
After culturing for 2 hours under the conditions of 7 ° C. and 10% CO 2 , 0.3 ml of the medium is sucked from each well and the remaining amount of the medium is 0.2
ml. Then WST-1 and 1-methoxy PMS
2 solution of the above cell counting kit containing
0 μl was added and shaken, and the cells were cultured in a CO 2 incubator at 37 ° C. and 10% CO 2 for 2 hours. During this culture, the cells were shaken again after 1 hour. Then, after culturing for 2 hours, the 48-well plate was cooled, and then the supernatant of each well was 110 μm with a micropipette.
1 was sampled and injected into a 96-well plate. Then, the absorbance of WST-1 formazan (measurement wavelength 450 nm, reference wavelength 650 nm) in each well of the 96-well plate was measured using a plate reader, and the absorbance (ΔOD obtained by subtracting the blank value of the medium alone was measured.
450-650 nm / hr, absorbance per hour of reaction,
OD / hr). The result is shown in FIG. The measurement result was the average value of the absorbance of 3 wells. However, the measurement results on the 15th and 30th days except the storage temperature of 30 ° C are the average value of the absorbance of 2 wells, and the storage temperature is 3
The measurement was stopped at 0 ° C until the 15th day, and the measurement result on the 15th day was the absorbance of one well.
【0029】図2において、急激なLDH酵素活性の低
下が保存直後に観察できるが、保存15日目以降はLD
H酵素活性は安定していることがわかる。特に、保存温
度が12℃の場合、LDH酵素活性が最も高く維持され
ていることがわかる。さらに、全保存温度における経時
変化が、同様の傾向を示していることがグラフの形状か
ら見て取れる。In FIG. 2, a sharp decrease in LDH enzyme activity can be observed immediately after storage, but after 15 days of storage, LD
It can be seen that the H enzyme activity is stable. In particular, it can be seen that the LDH enzyme activity is maintained at the highest when the storage temperature is 12 ° C. Further, it can be seen from the shape of the graph that the changes over time at all storage temperatures show the same tendency.
【0030】(3)移植適正の判定
上記酵素活性測定をもとに移植適正判定を行ったときの
適合例数を表3に示した。ここでは、各保存温度の3ウ
ェルの吸光度につき0.012(ml/cm2)*(O
D/hr)(注:シート1cmを1ml中で1時間反応
させたときの吸光度)を越えているものを適合と判定し
た場合、比較例1の適合例数と非常に良く一致したた
め、この数値を移植判定基準値(図2における「適合
値」)とした。表3では、測定例数を分母とし、適合例
数を分子とした。(3) Judgment of transplantation suitability Table 3 shows the number of compatible cases when the transplantation adequacy was judged based on the above enzyme activity measurement. Here, 0.012 (ml / cm 2 ) * (O
D / hr) (Note: the absorbance when 1 cm of the sheet was reacted in 1 ml for 1 hour) was judged to be conforming, the result was in good agreement with the number of conforming examples in Comparative Example 1. Was used as the transplantation judgment standard value (“adaptation value” in FIG. 2). In Table 3, the number of measurement examples was used as the denominator, and the number of compatible cases was used as the numerator.
【0031】[0031]
【表3】 [Table 3]
【0032】本実施例では、酵素活性測定試薬であるセ
ル・カウンティング・キットを用いて培養細胞シートの
パンチ片中のLDH酵素活性を分光学的に定量して数値
化したが、このLDH酵素活性は生細胞数と相関がある
ため結果的に生細胞数と同一視でき、その数値でもって
移植適正を判定するので、細胞数を顕微鏡下でカウント
するという手間をかけることなく容易に判定できる。ま
た、本実施例では、移植判定基準値(移植判定基準吸光
度)を適切に設定することにより、従来のトリパンブル
ーによる色素排除試験の結果に基づいて移植適正を判定
する場合と同等の結果が得られる。更に、培養細胞シー
トのパンチ片をそのまま測定対象として生細胞数を調べ
るため、ダメージを与えた後に生細胞数を調べる場合に
比べて、移植しようとする培養組織内の生細胞数を反映
した適切な結果が得られる。In this example, the LDH enzyme activity in the punch pieces of the cultured cell sheet was quantified spectroscopically and quantified using a cell counting kit, which is an enzyme activity measuring reagent. Can be identified with the number of living cells as a result because it correlates with the number of living cells, and the transplantability is determined based on that number, so the number of cells can be easily determined without the trouble of counting under a microscope. In addition, in the present example, by appropriately setting the transplantation determination standard value (transplantation determination standard absorbance), the same result as in the case of determining the transplantability based on the result of the conventional dye exclusion test with trypan blue was obtained. To be Furthermore, since the number of viable cells is measured by directly using the punched piece of the cultured cell sheet as a measurement target, it is more appropriate to reflect the number of viable cells in the cultured tissue to be transplanted than when the number of viable cells is examined after damage is given. Results are obtained.
【0033】比較例2.顕微鏡検査(鏡検ともいう)に
よるコロニー形成能確認
トリパンブルーによる色素排除試験の際にトリプシン処
理を行った細胞懸濁液を、培養上皮シートと同密度にな
るように、48ウェルプレート(0.75cm 2/ウェ
ル)に再播種し、1週間培養してコロニーを形成させ
た。その後、ローダニルブルーによりコロニーを染色
し、顕微鏡下で観察しながらコロニー数を計測した。な
お、各保存温度について3例(No.1〜3)計測し
た。その結果を表4に示す。この表4から明らかなよう
に、保存後2日目では全例がコロニー形成能を維持して
いた。また、保存温度6℃では保存後4日目まで、保存
温度12℃では保存後30日目まで、保存温度25℃で
は保存後15日目まで、保存温度30℃では保存後2日
まで、全例がコロニー形成を示した。また、表4のトー
タルの欄では、測定例数を分母とし、適合例数(適合例
とはコロニー形成能ありのもの)を分子とした。Comparative Example 2. For microscopy (also called microscopy)
Confirm colony forming ability
Trypsin treatment during dye exclusion test with trypan blue
Treated cell suspension to the same density as the cultured epithelial sheet.
48 well plate (0.75 cm 2/ We
Re-seeding and culturing for 1 week to form colonies
It was Then stain the colonies with Rhodanil blue
Then, the number of colonies was counted while observing under a microscope. Na
Oh, I measured 3 cases (No. 1-3) for each storage temperature.
It was The results are shown in Table 4. As is clear from Table 4
In addition, on the second day after storage, all cases maintained colony forming ability.
I was there. Also, at a storage temperature of 6 ° C, store until the 4th day after storage.
At a temperature of 12 ℃, 30 days after storage, at a storage temperature of 25 ℃
Up to 15 days after storage, 2 days after storage at 30 ° C
Until now, all cases showed colony formation. Also, the toe in Table 4
In the tal column, the number of measurement cases is used as the denominator
Is a colony-forming agent).
【0034】[0034]
【表4】 [Table 4]
【0035】実施例2.酵素活性測定によるコロニー形
成能確認
比較例2と同様にしてコロニーを形成させた後、前出の
セル・カウンティング・キットによるコロニー形成能確
認試験を行った。即ち、ウェルを新たな培地200μl
で置換し、30分間プレインキュベーションを行った
後、セル・カウンティング・キットの溶液20μlを添
加した。正確に1時間培養したあと冷却し、その後培地
110μlをサンプリングして吸光度(測定波長450
nm、参照波長650nm)を測定し、培地単独のブラ
ンク値を差し引いた吸光度(△OD 450-650nm/hr、
但しOD/hrとも記す)の3ウェルの平均値を求め
た。その結果を図3に示す。Example 2. Colony shape by enzyme activity measurement
Confirmation of ability
After forming colonies in the same manner as in Comparative Example 2,
Confirmation of colony forming ability with cell counting kit
An approval test was conducted. That is, the well was replaced with 200 μl of fresh medium
And preincubated for 30 minutes
Then add 20 μl of the cell counting kit solution.
Added Incubate for exactly 1 hour, then cool, then culture medium
Absorbance (measurement wavelength 450
nm, reference wavelength 650 nm), and culture medium alone
Absorbance (△ OD 450-650nm/ Hr,
However, the average value of 3 wells (also referred to as OD / hr) is calculated.
It was The result is shown in FIG.
【0036】上記酵素活性測定をもとに移植適正判定を
行ったときの適合例数を表5に示した。ここでは、各保
存温度の3ウェル(No.1〜3)の吸光度につき、
0.05(ml/cm2)*(OD/hr)を越えてい
るものを適合と判定した場合、比較例2の適合例数と非
常に良く一致したため、この数値を移植判定基準値(図
3における「カットライン」)とした。表5のトータル
の欄では、測定例数を分母とし、適合例数を分子とし
た。Table 5 shows the number of compatible cases when the transplant appropriateness was determined based on the above enzyme activity measurement. Here, for the absorbance of 3 wells (No. 1-3) at each storage temperature,
When the number of samples that exceeded 0.05 (ml / cm 2 ) * (OD / hr) was determined to be compatible, the number of compatible examples in Comparative Example 2 was very well matched. “Cut line” in 3). In the total column of Table 5, the number of measurement examples was used as the denominator, and the number of compatible cases was used as the numerator.
【0037】[0037]
【表5】 [Table 5]
【0038】本実施例では、酵素活性測定試薬であるセ
ル・カウンティング・キットを用いてコロニー中のLD
H酵素活性を分光学的に定量して数値化したが、このL
DH酵素活性はコロニー数と相関があるため結果的にコ
ロニー数と同一視でき、その数値でもって移植適正を判
定するので、コロニー数を顕微鏡下でカウントするとい
う手間をかけることなく容易に判定できる。また、本実
施例では、移植判定基準値(移植判定基準吸光度)を適
切に設定することにより、従来のコロニー数をカウント
する場合と同等の移植適正判定結果が得られる。In this example, LD in a colony was prepared using a cell counting kit which is an enzyme activity measuring reagent.
H enzyme activity was quantified spectroscopically and quantified.
Since the DH enzyme activity has a correlation with the number of colonies, as a result, it can be identified with the number of colonies, and the appropriateness of transplantation is determined based on the number, so that the number of colonies can be easily determined without the trouble of counting under a microscope. . In addition, in this example, by appropriately setting the transplantation determination reference value (transplantation determination reference absorbance), a transplantation appropriateness determination result equivalent to that obtained when counting the number of conventional colonies can be obtained.
【0039】なお、本発明は上記実施例に何等限定され
るものではなく、など、本発明の技術的範囲を逸脱しな
い範囲内において、種々なる形態で実施し得ることは勿
論である。It should be noted that the present invention is not limited to the above-described embodiments, and it is needless to say that the present invention can be implemented in various forms without departing from the technical scope of the present invention.
【図1】トリパンブルーによる色素排除試験における、
保存日数と生細胞率の変化を表すグラフである。FIG. 1 shows a dye exclusion test using trypan blue.
It is a graph showing the change of the number of preservation days and the viable cell rate.
【図2】酵素活性測定における、保存日数と吸光度(生
細胞率)の変化を表すグラフである。FIG. 2 is a graph showing changes in the number of storage days and the absorbance (viable cell rate) in enzyme activity measurement.
【図3】酵素活性測定における、保存日数と吸光度(コ
ロニー形成能)の変化を表すグラフである。FIG. 3 is a graph showing changes in storage days and absorbance (colony forming ability) in enzyme activity measurement.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 井家 益和 愛知県蒲郡市三谷北通6丁目209番地の1 株式会社ジャパン・ティッシュ・エンジ ニアリング内 (72)発明者 篠原 力 愛知県蒲郡市三谷北通6丁目209番地の1 株式会社ジャパン・ティッシュ・エンジ ニアリング内 Fターム(参考) 2G045 AA24 BA14 BB20 BB25 CB01 DA20 FA16 FB01 FB11 FB12 GC10 GC22 4B063 QA05 QQ08 QQ24 QQ61 QR04 QR41 QR64 QR77 QX01 ─────────────────────────────────────────────────── ─── Continued front page (72) Inventor Ikazu Masuwa 1-209-6-chome, Mitanikitadori, Gamagori-shi, Aichi Japan Tissue Engineering Co., Ltd. In nearing (72) Inventor Riki Shinohara 1-209-6-chome, Mitanikitadori, Gamagori-shi, Aichi Japan Tissue Engineering Co., Ltd. In nearing F-term (reference) 2G045 AA24 BA14 BB20 BB25 CB01 DA20 FA16 FB01 FB11 FB12 GC10 GC22 4B063 QA05 QQ08 QQ24 QQ61 QR04 QR41 QR64 QR77 QX01
Claims (10)
組織状態のまま測定対象とし、該測定対象である培養組
織中の細胞内酵素を反応させることにより自らは分光学
的に測定可能な物質に変換される酵素活性測定試薬で処
理し、その変換後の前記物質を分光学的に定量し、その
定量結果に基づいて前記培養組織の移植適正を判定する
移植適正判定方法。1. It is possible to measure spectroscopically by subjecting a cultured tissue after culturing to a measurement target in the tissue state without performing a dispersion treatment and reacting an intracellular enzyme in the culture target tissue to be measured. A method for determining the adequacy of transplantation, which is treated with an enzyme activity measuring reagent that is converted into a substance, spectroscopically quantifies the substance after the conversion, and determines the transplantability of the cultured tissue based on the quantification result.
た分散細胞を再播種し培養してコロニーを形成させて測
定対象とし、該測定対象であるコロニー中の細胞内酵素
を反応させることにより自らは分光学的に測定可能な物
質に変換される酵素活性測定試薬で処理し、その変換後
の前記物質を分光学的に定量し、その定量結果に基づい
て前記培養組織の移植適正を判定する移植適正判定方
法。2. The dispersed cells obtained by subjecting the cultured tissue after the culturing to the dispersion treatment are re-seeded and cultured to form colonies to be a measurement target, and the intracellular enzyme in the colony as the measurement target is reacted. By itself, it is treated with an enzyme activity measuring reagent that is converted into a spectroscopically measurable substance, the substance after the conversion is spectroscopically quantified, and the transplantability of the cultured tissue is determined based on the quantitative result. A method for determining the appropriateness of transplantation.
項2記載の移植適正判定方法とを併用する移植適正判定
方法。3. A transplant adequacy determination method using the transplant adequacy determination method according to claim 1 and the transplant adequacy determination method according to claim 2.
トの一部を切り取って得られた部分培養細胞シートであ
る請求項1〜3のいずれかに記載の移植適正判定方法。4. The transplantation adequacy determining method according to claim 1, wherein the cultured tissue after the culture is a partially cultured cell sheet obtained by cutting a part of the cultured cell sheet.
である培養組織中の細胞内脱水素酵素を反応させること
により自らは還元されて特定波長を吸収する物質に変換
される酸化還元型試薬である請求項1〜4のいずれかに
記載の移植適正判定方法。5. The redox-type reagent, wherein the enzyme activity measuring reagent is reduced by itself by reacting with intracellular dehydrogenase in the cultured tissue to be measured and converted into a substance absorbing a specific wavelength. 5. The transplant adequacy determining method according to claim 1, wherein
塩である請求項5記載の移植適正判定方法。6. The transplantability determining method according to claim 5, wherein the redox reagent is a tetrazolium salt.
T、WST−1及びWST−8からなる群より選ばれた
1つである請求項6記載の移植適正判定方法。7. The tetrazolium salt is XTT or MT.
The transplant adequacy determination method according to claim 6, which is one selected from the group consisting of T, WST-1 and WST-8.
である培養組織中の細胞内加水分解酵素を反応させるこ
とにより自らは加水分解を受けて蛍光を発する物質に変
換される分解蛍光型試薬である請求項1〜4のいずれか
に記載の移植適正判定方法。8. The degradable fluorescence type reagent, wherein the enzyme activity measuring reagent is converted into a substance which is hydrolyzed by itself by reacting with an intracellular hydrolase in the cultured tissue as the measurement target. 5. The transplant adequacy determining method according to claim 1, wherein
フルオレセインである請求項8記載の移植適正判定方
法。9. The transplantation adequacy determining method according to claim 8, wherein the degradable fluorescent reagent is an ester group-containing fluorescein.
は、カルセイン−AMである請求項9記載の移植適正判
定方法。10. The transplantation adequacy determining method according to claim 9, wherein the ester group-containing fluorescein is calcein-AM.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001242648A JP2003052395A (en) | 2001-08-09 | 2001-08-09 | Transplant adequacy determination method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001242648A JP2003052395A (en) | 2001-08-09 | 2001-08-09 | Transplant adequacy determination method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003052395A true JP2003052395A (en) | 2003-02-25 |
Family
ID=19072888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001242648A Pending JP2003052395A (en) | 2001-08-09 | 2001-08-09 | Transplant adequacy determination method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003052395A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004083452A1 (en) * | 2003-03-17 | 2004-09-30 | Dojindo Laboratories Co., Ltd. | Method of diagnosing carrier of glucose-6-phosphate dehydrogenase deficiency |
| WO2007145333A1 (en) * | 2006-06-15 | 2007-12-21 | National University Corporation, Tokyo Medical And Dental University | Immunity evaluation method, immunity evaluation apparatus, immunity evaluation program and data recording medium having the immunity evaluation program stored therein |
| WO2010070908A1 (en) * | 2008-12-18 | 2010-06-24 | 国立大学法人東京医科歯科大学 | Immunity evaluation method, apparatus and program |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1099096A (en) * | 1995-12-29 | 1998-04-21 | Ishihara Sangyo Kaisha Ltd | Number counting of survived cell |
| JPH10337180A (en) * | 1997-06-06 | 1998-12-22 | Res Dev Corp Of Japan | Hepatocyte culture method |
| WO2000013015A1 (en) * | 1998-08-26 | 2000-03-09 | Cephalon, Inc. | Modulating multiple lineage kinase proteins |
| JP2000512666A (en) * | 1996-05-22 | 2000-09-26 | ベン―グリオン ユニバーシティー オブ ザ ネゲブ | Polysaccharide sponges for cell culture and transplantation |
-
2001
- 2001-08-09 JP JP2001242648A patent/JP2003052395A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1099096A (en) * | 1995-12-29 | 1998-04-21 | Ishihara Sangyo Kaisha Ltd | Number counting of survived cell |
| JP2000512666A (en) * | 1996-05-22 | 2000-09-26 | ベン―グリオン ユニバーシティー オブ ザ ネゲブ | Polysaccharide sponges for cell culture and transplantation |
| JPH10337180A (en) * | 1997-06-06 | 1998-12-22 | Res Dev Corp Of Japan | Hepatocyte culture method |
| WO2000013015A1 (en) * | 1998-08-26 | 2000-03-09 | Cephalon, Inc. | Modulating multiple lineage kinase proteins |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004083452A1 (en) * | 2003-03-17 | 2004-09-30 | Dojindo Laboratories Co., Ltd. | Method of diagnosing carrier of glucose-6-phosphate dehydrogenase deficiency |
| WO2007145333A1 (en) * | 2006-06-15 | 2007-12-21 | National University Corporation, Tokyo Medical And Dental University | Immunity evaluation method, immunity evaluation apparatus, immunity evaluation program and data recording medium having the immunity evaluation program stored therein |
| JPWO2007145333A1 (en) * | 2006-06-15 | 2009-11-12 | 国立大学法人 東京医科歯科大学 | Immune power evaluation method, immunity evaluation apparatus, immunity evaluation program, and information recording medium recording the immunity evaluation program |
| JP4608704B2 (en) * | 2006-06-15 | 2011-01-12 | 国立大学法人 東京医科歯科大学 | Immune power evaluation method, immunity evaluation apparatus, and immunity evaluation program |
| US8815524B2 (en) | 2006-06-15 | 2014-08-26 | National University Corporation, Tokyo Medical And Dental University | Immunity evaluation method, immunity evaluation apparatus, immunity evaluation program and data recording medium having the immunity evaluation program stored therein |
| WO2010070908A1 (en) * | 2008-12-18 | 2010-06-24 | 国立大学法人東京医科歯科大学 | Immunity evaluation method, apparatus and program |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ingham et al. | Soil fungi: relationships between hyphal activity and staining with fluorescein diacetate | |
| Söderström | Vital staining of fungi in pure cultures and in soil with fluorescein diacetate | |
| US5491069A (en) | Biomarkers of cell senescence | |
| Brusuker et al. | β‐Galactosidase—An indicator of the maturational stage of mouse and human mononuclear phagocytes | |
| CA2403253A1 (en) | Measuring metabolic rate changes | |
| Miyamoto et al. | Establishment of fluorescein diacetate and ethidium bromide (FDAEB) assay for quality assessment of isolated islets | |
| CN104694464A (en) | Clinical dental pulp stem cell and preparation method thereof | |
| Matsumae et al. | Evaluation of the differentiation status of single embryonic stem cells using scanning electrochemical microscopy | |
| Gray | 10 Methods for Studying the Microbial Ecology of Soil | |
| CN102539401B (en) | Method for quickly detecting microorganisms | |
| JP2003052395A (en) | Transplant adequacy determination method | |
| MacDonald | Cytochemical demonstration of catabolism in soil micro-organisms | |
| Stier et al. | On the production and use of permanently altered strains of yeast for studies of in vivo metabolic organization | |
| Vanoni et al. | Effects of temperature on the yeast cell cycle analyzed by flow cytometry | |
| Kumar et al. | Ultrastructural and biochemical development of the photosynthetic apparatus during callus induction in carrot root explants | |
| Stoner et al. | Putrescine stimulates growth of human bronchial epithelial cells in primary culture | |
| Chacón et al. | Biomarkers of geno-and cytotoxicity in the native broad-snouted caiman (Caiman latirostris): Chromosomal aberrations and mitotic index | |
| Keagle et al. | Basic laboratory procedures | |
| EP4239057A1 (en) | Culture medium composition for establishing or culturing keratinocytes comprising calcium, epideral growth factor, and albumin | |
| RU1766073C (en) | Strain of fungus aspergillus flavus link as a test-culture for steel, oxide aluminium and magnesium alloys mycoresistance assay | |
| Freese et al. | The influence of the developing bacterial spore on the mother cell | |
| JP2003116591A (en) | Method and apparatus for evaluating metabolic function of microorganism | |
| EP4435094A1 (en) | Cell population including mesenchymal stem cells, cell sheet, and cell sheet production method | |
| CN119265272A (en) | A method for detecting cell stability | |
| Gahan | Quantitative enzyme cytochemistry in plant biotechnology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20031031 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20040129 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070928 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20071210 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100720 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101130 |